SynBioBeta 2026 Speaker

Rimma Boshernitsan

DIALOGUE

CEO, Futurist, Strategist

Rimma Boshernitsan is a futurist, strategist, and the founder and CEO of DIALOGUE, an interdisciplinary strategic advisory that helps leaders stop reacting to the zeitgeistโ€”and start shaping it. Over the course of a 20-year career, she has served as a strategic advisor and thought partner to CEOs of emerging businesses and Fortune 500 organizations, including Apple, Tata, Roche, Google, Kaiser Permanente, Aesop, Leviโ€™s, Lyft, Kraft Foods, and Chevron. She has worked internationally, including in Moscow, London, and throughout the U.S.Rimma began her career at Deloitte Consultingโ€™s Human Capital practice, where she focused on M&A and large-scale transformation, before moving into in-house advisory work across healthcare, consumer business, and telecommunications. A period advising contemporary art collectors sharpened her sensitivity to how cultural, political, and scientific shifts often emerge at the edges of institutions before becoming strategic imperatives within them. That insight led her to found DIALOGUE.At the center of Rimmaโ€™s work is a model she calls the Triad of Intelligences: human intelligence, machine intelligence, and planetary intelligence. Her work on co-intelligence is not in biotech itself, but adjacent and highly relevant to itโ€”focused on how societies, institutions, and leaders make wiser decisions about health, healthspan, longevity, and the conditions that allow life to flourish. She explores how human intuition, ethical judgment, and living systems awareness must evolve alongside technical capability if innovation is to remain coherent, evidence-based, and humane. In her recent work, including her Noema essay and talks on a planetary nervous system, she argues that health is not only a clinical question, but a systems question. ๏ฟผ ๏ฟผRimmaโ€™s expertise moves across strategic foresight, AI transformation, and co-intelligent leadership. She has spoken and moderated at SXSW, the Swiss Consulate, WRLDCTY, and other public forums, and is known for guiding conversations that connect frontier innovation to its broader human, ethical, and societal implications. At SynBioBeta, she brings an interdisciplinary lens to the frontier of longevity scienceโ€”focused less on the lab itself than on the larger questions of judgment, coherence, healthspan, and human consequence that emerge around it.

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor splatter with lime dots
Blue watercolor splatter
Speaker photo

Reagan

Jarvis

Anocca AB

CEO, Co-founder

Speaker photo

Alex

Rives

CZI Biohub

Head of Science

Speaker photo

Karenโ€ฏ

Akinsanya

Schrodinger

President, R&D โ€“ Therapeutics

Speaker photo

Christopher

Arendt

Takeda

CSO, Head of Research

Speaker photo

Stef

van Grieken

Cradle

CEO

Speaker photo

Michael

Koeris

DARPA

Director, BTO

Speaker photo

Jennifer

Dionne

Pumpkinseed

CEO

Speaker photo

Daniyal

Hussain

GSK

Exec. Dir., Tech BD

Speaker photo

Cynthia

Hong

Novartis

Dir., Search & Evaluation

Speaker photo

Sarah Lynn

Tao

CSL Behring

Sr. Dir., S&E; Ig TA & Tech Lead

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure

SynBioBeta 2027 May 3-6, San Jose, California